Activation mechanism of the μ-opioid receptor by an allosteric modulator.
Activation mechanism of the μ-opioid receptor by an allosteric modulator.
复制标题
DOI:
10.1073/pnas.2121918119
复制
发表时间:
2022-04-19
影响因子:
11.1
通讯作者:
中科院分区:
文献类型:
--
作者:
The allosteric modulators, which bind to nonorthosteric sites to enhance the signaling activities of G-protein-coupled receptors (GPCRs), are new candidates for GPCR-targeting drugs. Our solution NMR analyses of the μ-opioid receptor (MOR) revealed that the MOR activity was determined by a conformational equilibrium between three conformations. Interestingly, an allosteric modulator shifted the equilibrium toward a conformation with the highest activity to a level that cannot be reached by orthosteric ligands alone, leading to the increased activity of MOR. Our NMR analyses also identified the binding site of the allosteric modulator, including the residues contributing to the regulation of the equilibrium. These findings provide insights into the rational developments of novel allosteric modulators. Allosteric modulators of G-protein-coupled receptors (GPCRs) enhance signaling by binding to GPCRs concurrently with their orthosteric ligands, offering a novel approach to overcome the efficacy limitations of conventional orthosteric ligands. However, the structural mechanism by which allosteric modulators mediate GPCR signaling remains largely unknown. Here, to elucidate the mechanism of μ-opioid receptor (MOR) activation by allosteric modulators, we conducted solution NMR analyses of MOR by monitoring the signals from methionine methyl groups. We found that the intracellular side of MOR exists in an equilibrium between three conformations with different activities. Interestingly, the populations in the equilibrium determine the apparent signaling activity of MOR. Our analyses also revealed that the equilibrium is not fully shifted to the conformation with the highest activity even in the full agonist-bound state, where the intracellular half of TM6 is outward-shifted. Surprisingly, an allosteric modulator for MOR, BMS-986122, shifted the equilibrium toward the conformation with the highest activity, leading to the increased activity of MOR in the full agonist-bound state. We also determined that BMS-986122 binds to a cleft in the transmembrane region around T162 on TM3. Together, these results suggest that BMS-986122 binding to TM3 increases the activity of MOR by rearranging the direct interactions of TM3 and TM6, thus stabilizing TM6 in the outward-shifted position which is favorable for G-protein binding. These findings shed light on the rational developments of novel allosteric modulators that activate GPCRs further than orthosteric ligands alone and pave the way for next-generation GPCR-targeting therapeutics.
登录
查看更多内容
影响因子:
64.8
作者:
Koehl A;Hu H;Maeda S;Zhang Y;Qu Q;Paggi JM;Latorraca NR;Hilger D;Dawson R;Matile H;Schertler GFX;Granier S;Weis WI;Dror RO;Manglik A;Skiniotis G;Kobilka BK
通讯作者:
Kobilka BK
DOI:
10.1038/nrd2760
发表时间:
2009-01
期刊:
Nature reviews. Drug discovery
影响因子:
--
作者:
通讯作者:
--
影响因子:
7.3
作者:
Burford, Neil T.;Livingston, Kathryn E.;Alt, Andrew
通讯作者:
Alt, Andrew
DOI:
10.1126/science.1215802
发表时间:
2012-03-02
期刊:
Science (New York, N.Y.)
影响因子:
--
作者:
Liu JJ;Horst R;Katritch V;Stevens RC;Wüthrich K
通讯作者:
Wüthrich K
影响因子:
16.6
作者:
通讯作者:
--